Knowledge, Attitude, Practice and Stigma Related to COVID-19: A Nigerian Perspective
Povzetek
Pandemics have claimed an estimated 414 million lives from 165 AD to present, with COVID-19 pandemic killing close to 2 million people. The best counter for pandemics has been the use of vaccines, but before it is widely available, the best strategy is to avoid being infected. COVID-19 pandemic was met by behaviours and attitudes ranging from unbelief to fear of dying and stigmatisation of those who have contracted the virus or recovered from the disease. This study aimed to investigate the knowledge, attitudes, practices (KAP), fear and stigma of the populace towards COVID-19 from state to state. This research was a cross-sectional study carried out from April to October 2020. Data was obtained through a structured questionnaire distributed to 650 individuals. Respondents who participated were 591 (males n= 335 and females n= 256) and aged 18-60 years (mean age 30.25 ± 10.45 years, range 18-60) drawn from five states in the north-central region of Nigeria. The results show that 98.3% of participants believe that COVID-19 disease exists. Still, not everyone wears face masks, avoid crowded places, practice social distancing or follow the WHO-hand-washing technique as measures to curb the spread of the disease. Only 60.5% of the participants believe that lockdown is an effective measure to reduce transmission risk. 55.6% will stigmatise those who just recovered from the disease, 75.3% are afraid to visit high-risk areas as part of the protective measures, but only about 12% believe that every infected person will die. More males (28.3%) than females (17.6%) believe that taking herbs can cure the disease (P<0.01). All government and nongovernmental organizations must develop more awareness programs to win the battle against COVID-19 disease as the second wave is emerging.
Literatura
Abdel Wahed, W.Y., Hefzy, E.M., Ahmed, M.I. & Hamed, N.S. (2020). Assessment of knowledge, attitudes, and perception of health care workers regarding COVID‑19, A cross‑sectional study from Egypt. Journal of Community Health 45:1242–1251. https://doi.org/10.1007/s10900-020-00882-0
Adesegun, O.A., Binuyo, T., Adeyemi, O., Ehioghae, O., Rabor, D.F., Amusan, O., Akinboboye, O., Duke, O.F., Olafimihan, A.G., Ajose, O., Idowu, A.O. & Abiodun, O (2020). The COVID-19 crisis in sub-Saharan Africa: Knowledge, attitudes, and practices of the Nigerian Public. Am. J. Trop. Med. Hyg., 103(5), 1997–2004. doi:10.4269/ajtmh.20-0461
Afro News (2020). Afro.who.int/news/second-covid-19-cases-confirmed-africa.
Ajide, K.B., Ibrahima, R.L. & Alimi, O.Y. (2020). Estimating the impacts of lockdown on Covid-19 cases in Nigeria. Transportation Research Interdisciplinary Perspectives 7 http://dx.doi.org/10.1016/j.trip.2020.100217
Akin, L. & Gözel, M.G. (2020). Understanding dynamics of pandemics. Turkish Journal of Medical Sciences, 50: 515-519. doi:10.3906/sag-2004-133.
Al-Dossary, R., Alamri, M., Albaqawi, H., Al Hosis, K., Aljeldah, M., Aljohan, M., Aljohani, K., Almadani, N., Alrasheadi, B., Falatah, R. & Almazan, J. (2020). Awareness, attitudes, prevention, and perceptions of COVID-19 outbreak among nurses in Saudi Arabia. International Journal of Environmental Research and Public Health, 17, 8269; doi:10.3390/ijerph17218269
Alobuia, W.M., Dalva-Baird, N.P., Forrester, J.D., Bendavid, E. & Bhattacharya, J. Electron Kebebew. Racial disparities in knowledge, attitudes and practices related to COVID-19 in the USA. J Public Health (Oxf). 2020 Aug 18;42(3):470-478. doi:10.1093/pubmed/fdaa069.
Al-Tawfiq, J.A. (2020). Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel Medicine and Infectious Disease, 35:101608 https://doi.org/10.1016/j.tmaid.2020.101608
Arinola, O.G. (2020). Immune responses during human Coronavirus infection: Suggestions for future studies. Niger. J. Physiol. Sci. 35: 20-25.
Asraf, H., Garima, T., Singh, B.M., Ram, R. & Tript, R.R. (2020). Knowledge, attitudes and Practices towards COVID-19 among Nepalese Residents: A quick online cross-sectional survey. Asian Journal of Medical Sciences; 11(3): 6-11.
Azlan, A.A., Hamzah, M.R., Sern, T.J., Ayub, S.H. & Mohamad, E. (2020). Public knowledge, attitudes and practices towards COVID-19: A cross-sectional study in Malaysia. PLoS ONE 15(5): e0233668. https://doi.org/10.1371/journal.pone.0233668
Bates, B.R., Moncayo, A.L., Costales, J.A., Herrera‑Cespedes, C.A. & Grijalva, M.J. (2020). Knowledge, attitudes, and practices towards covid‑19 among Ecuadorians during the outbreak: An online cross‑sectional survey. Journal of Community Health, 45:1158–1167. https://doi.org/10.1007/s10900-020-00916-7
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F. & Yang, H. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet; 395: 507-513.
Du, Z., Xu, X., Wu, Y., Wang, L., Cowling, B.J. & Meyers, L.A. (2020). Serial interval of COVID-19 among publicly reported confirmed cases. Emerging Infectious Diseases; 26(6): 1341-1343.
Danborno, A.M., Tarfa, F.D., Toryila, J.E., Awheela, E.U. & Shekarau, V.T (2019). The Effects of Jatropha tanjorensis Aqueous Extract on Haematological Parameters in Wistar Rats. Journal of African Association of Physiological Sciences, 7(2): 133-137.
EBioMedicine. (2020). Race for a COVID-19 vaccine. EBioMedicine, 55:102817. https://doi.org/10.1016/j.ebiom.2020.10281710
Haque, A. & Pant, A. B. (2020). Efforts at COVID-19 vaccine development: Challenges and successes. Vaccines, 8, 739; doi:10.3390/vaccines8040739
Hossain, M.A., Jahid, M.I.K, Hossain, K.M.A., Walton, L.M., Uddin, Z., Haque, M.O, et al. (2020). Knowledge, attitudes, and fear of COVID-19 during the Rapid Rise Period in Bangladesh. PLoS ONE, 15(9): e0239646. https://doi.org/10.1371/journal.pone.0239646
Jeyanathan, M., Afkhami, S., Smaill, F. et al. (2020). Immunological considerations for COVID-19 vaccine strategies. Nature Review Immunology, 20, 615–632. https://doi.org/10.1038/s41577-020-00434-6
Jones, J., Sullivan, P.S., Sanchez, T.H., Guest, J.L., Hall, E.W., Luisi, N., Zlotorzynska, M., Wilde G., Bradley, H., Siegler, A.J. (2020). Similarities and differences in COVID-19 awareness, concern, and symptoms by race and ethnicity in the United States: Cross-sectional survey. Journal of Medical Internet Research, 22(7):e20001). doi: 10.2196/20001
Kannan, S., Ali, P.S.S., Sheeza, A., Hemalath, K (2020). COVID-19 (Novel Coronavirus 2019)-recent trends. European Review for Medical and Pharmacological Sciences, 24: 2006-2011.
Koirala, A., Joo Y. J. & A. Khatami, A. et al., (2020). Vaccines for COVID-19: The current state of play. Paediatric Respiratory Reviews, https://doi.org/10.1016/j.prrv.2020.06.010
Luo, H., Tang, Q. L., Shang, Y., Liang, S.B., Yang, M., Robinson, N., & Liu, J.P. (2020). Can Chinese medicine be used for prevention of coronavirus disease 2019 (COVID). A review of historical classics, research evidence and current prevention programs. Chinese Journal of Integrative Medicine, 26(4): 243-250.
Morens, D.M., Daszak, P., Markel, H., Taubenberger, J.K. (2020). Pandemic COVID-19 joins history's pandemic legion. mBio 11: e00812-20. https://doi.org/10.1128/mBio.00812-20.
Moses, M.O., Emikpe, A.O., Moses, M.K., & Emikpe, B. O. (2020). Combating COVID-19 lockdown inactivity in the African population: Use of cultural practices and One Health Approach. Niger. J. Physiol. Sci. 35: 4-9.
Nigerian Center for Disease Control (NCDC) (2020a). Ncdc.gov.ng/news/227/first-case-of-corona-virus-disease-comfirmed-in-nigeria.
Nigeria Centre for Disease Control (NCDC), (2020b). Confirmed COVID-19 cases by state. Available at. https://covid19.ncdc.gov.ng/.
Ogoina, D. (2020). COVID-19 and the rest of us. Niger Delta Medical Journal, 4:6–8.
Olaimat, A.N., Aolymat, I., Elsahoryi, N., Shahbaz, H.M. & Holley, R.A. (2020). Attitudes, anxiety, and behavioral practices regarding COVID-19 among University Students in Jordan: A cross-sectional study. American Journal of Tropical Medicine and Hygiene, 103(3): 1177–1183. doi:10.4269/ajtmh.20-0418
Owoyele, B.V., Bakare, A.O. & Ologe, M.O. (2020). Bromelain: A Review of its Potential as a Therapy for the Management of COVID-19. Niger. J. Physiol. Sci. 35: 10-19.
Paakkari, L. & Okan, O. (2020). COVID-19: health literacy is an underestimated problem. The Lancet Public Health, 5(5): E249-E250.
Peiris, M. & Leung, G. M. (2020) What can we expect from first-generation COVID-19 vaccines? The Lancet, 396: 7. https://doi.org/10.1016/S0140-6736(20)31976-0
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., et al., (2020). Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine. https://doi.org/10.1056/NEJMc2001468.
Santarpia, J.L., Rivera, D.N., Herrera, V.L., Morwitzer, M.J., Creager, H.M., Santarpia, G.W. et al., (2020). Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Scientific Reports. 10,12732. Doi/10.1038/69286-3.
Sun, P., Lu, X., Xu, C., Sun, W. & Pan, B. (2020). Understanding of COVID‐19 based on current evidence. Journal of Medical Virology, 92:548–551. https://doi.org/10.1002/jmv.25722
Tripathi, D., Yi, G. & Vankayalapati. R. (2020). COVID-19: An update on vaccine development. Indian Journal of Rheumatology, 15:70-2.
Van Doremalen, N., Bushmaker, T. & Morrris, H.D. (2020). Aerosol and surface stability of SARS-CoV-1. New England Journal of Medicine, 382: 1564-1567.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B. et al., (2020). Clinical characteristics of 138 hospitalised patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11): 1061-1069.
Wang, J., Peng, Y., Xu, H., Cui, Z., & Williams III, R.O. (2020). The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS Pharm SciTech, 21: 225. DOI: 10.1208/s12249-020-01744-7.
World Health Organization (WHO). (2020a). 2019-nCoV outbreak is an emergency of international concern. http://www.euro.who.int/en/health-topics/emergencies/pages/news/news/ 2020/01/2019-ncov-outbreak-is-an-emergency-ofinternational-concern.
World Health Organization (WHO). (2020b). Draft landscape of COVID-19 candidate vaccines. Sept 9, 2020. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (accessed December 11, 2020).
World Health Organization (2020c). Questions and answers on coronaviruses (COVID‐19).
https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
World Health Organization (2020d). Coronavirus disease 2019 (COVID‐19) Situation Report – 51. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf
Yang, Y., Islam, M.S., Wang, J., Li, Y., & Chen, X. (2020). Traditional Chinese medicine in the treatment of patients infected with 2019-new Coronavirus (SARS-COV-2): A review and perspective. International Journal of Biological Sciences, 16(10): 1708-1717.
Objavljeno
Številka
Rubrika
Licenca
Avtorske pravice (c) 2021 Nigerian Journal of Physiological Sciences
To delo je licencirano pod Creative Commons Priznanje avtorstva 4.0 mednarodno licenco.
